No abstract available
Publication types
-
Clinical Trial, Phase I
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Brachytherapy / adverse effects*
-
Choroid Neoplasms / radiotherapy
-
Female
-
Fluorescein Angiography
-
Humans
-
Injections
-
Macula Lutea / radiation effects*
-
Macular Edema / drug therapy
-
Macular Edema / etiology
-
Male
-
Melanoma / radiotherapy
-
Middle Aged
-
Palladium / adverse effects
-
Radiation Injuries / drug therapy*
-
Radiation Injuries / etiology
-
Radioisotopes / adverse effects
-
Ranibizumab
-
Retinal Diseases / drug therapy*
-
Retinal Diseases / etiology
-
Retinal Hemorrhage / drug therapy
-
Retinal Hemorrhage / etiology
-
Retinal Neovascularization / drug therapy
-
Retinal Neovascularization / etiology
-
Tomography, Optical Coherence
-
Visual Acuity
-
Vitreous Body
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Radioisotopes
-
Palladium
-
Ranibizumab
Associated data
-
ClinicalTrials.gov/NCT00750399